Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Gainers

• Windtree Therapeutics Inc (NASDAQ:WINT) shares rose 65.3% to $0.28 in pre-market trading. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
• Cyren Ltd (NASDAQ:CYRN) rose 50.2% to $0.62 in pre-market trading after the company reported non-binding LOI to sell Iceland-based anti-malware business assets.
• Sorrento Therapeutics Inc (NASDAQ:SRNE) rose 44.4% to $0.56 in pre-market trading after the company received court approval for $75 million financing in Chapter 11 case.
• Wag! Group Co (NASDAQ:PET) rose 21.7% to $2.80 in pre-market trading after the company posted better-than-expected Q4 earnings.
• Greenlane Holdings Inc (NASDAQ:GNLN) rose 21.7% to $0.46 in pre-market trading after the company said it has reduced its current loan facility by over 40% to approximately $8.5 million, while also receiving more than $4.8 million from the sale of its Employee Retention Credit..
• Hoth Therapeutics Inc (NASDAQ:HOTH) shares rose 14.3% to $2.96 in pre-market trading after dropping over 9% on Tuesday. Hoth Therapeutics recently entered into a service agreement with Shareholder Intelligence Services to investigate and report on potential illegal naked short selling activities of its stock.
• Mind Medicine (MindMed) Inc (NASDAQ:MNMD) rose 10.7% to $4.20 in pre-market trading after dropping around 4% on Tuesday.
• Vinco Ventures Inc (NASDAQ:BBIG) shares rose 9.8% to $0.58 in pre-market trading after dropping 8% on Tuesday.
• 1life Healthcare Inc (NASDAQ:ONEM) rose 8.6% to $17.88 in pre-market trading following reports the Federal Trade Commission won't challenge Amazon.com's takeover bid. 1Life Healthcare also posted a Q4 loss of $0.49 per share.
• Palo Alto Networks Inc (NASDAQ:PANW) rose 8.2% to $180.62 in pre-market trading after the company reported better-than-expected Q2 results and issued strong guidance.

Losers

• Ambrx Biopharma Inc - ADR (NYSE:AMAM) shares fell 17.1% to $3.77 in pre-market trading after jumping 45% on Tuesday. Ambrx Biopharma recently announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx's proprietary anti-PSMA ADC, in prostate cancer patients.
• Ziprecruiter Inc (NYSE:ZIP) shares dropped 15.1% to $19.73 in pre-market trading after the company reported a 4% year-over-year decrease in Q4 revenue.
• CoStar Group Inc (NASDAQ:CSGP) fell 14.7% to $64.86 in pre-market trading after the company issued weak Q1 guidance.
• Esports Entertainment Group Inc (NASDAQ:GMBL) fell 13.7% to $5.11 in pre-market trading. Esports Entertainment Group announced a 1-for-100 reverse stock split.
• Harbor Custom Development Inc (NASDAQ:HCDI) fell 13.7% to $0.44 in pre-market. Harbor Custom Development, on Tuesday, announced it has contracted to sell the Mills Crossing townhomes in Bremerton, WA for $14,250,000 to Kitsap Community Resources.
• JE Cleantech Holdings Ltd (NASDAQ:JCSE) fell 11.2% to $0.67 in pre-market trading after dropping over 5% on Tuesday.
• eFFECTOR Therapeutics Inc (NASDAQ:EFTR) fell 10.5% to $0.45 in pre-market trading after dropping 20% on Tuesday. eFFECTOR Therapeutics announced top-line results from its Phase 1b clinical trial of zotatifin for COVID-19 infection.
• Nutex Health Inc (NASDAQ:NUTX) fell 10.4% to $1.19 in pre-market trading after declining around 4% on Tuesday.
• Kuke Music Holding Ltd - ADR (NYSE:KUKE) fell 9.4% to $0.97 in pre-market trading after jumping around 43% on Tuesday.
• Medifast Inc (NYSE:MED) shares fell 9% to $96.00 in pre-market trading after the company issued weak forecast for the current quarter.

Now Read This: NVIDIA Likely To Report Lower Quarterly Earnings, Here's A Look At Recent Price Target Changes By The Most Accurate Analysts